<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e>, also known as <z:hpo ids='HP_0002671'>Basal Cell Nevus</z:hpo> Syndrome (BCNS), is a rare <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder with complete penetrance and <z:hpo ids='HP_0003828'>variable expressivity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This syndrome is characterized by developmental anomalies, such as odentogenic <z:e sem="disease" ids="C0341038" disease_type="Disease or Syndrome" abbrv="">keratocysts</z:e> of the mandible and postnatal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, especially multiple <z:hpo ids='HP_0002671'>basal cell carcinomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of this syndrome is variously estimated to be 1 in 60,000 to 1 in 120,000 persons </plain></SENT>
<SENT sid="3" pm="."><plain>Mutation in a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor, the PTCH1 gene residing on long arm of Ch 9, is responsible for the development of many postnatal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e> show multiple abnormalities, none of which is unique to this condition </plain></SENT>
<SENT sid="5" pm="."><plain>Our case had almost <z:hpo ids='HP_0000001'>all</z:hpo> the features of this rare syndrome </plain></SENT>
</text></document>